BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schwimmer JB, Deutsch R, Rauch JB, Behling C, Newbury R, Lavine JE. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr. 2003;143:500-505. [PMID: 14571229 DOI: 10.1067/s0022-3476(03)00325-1] [Cited by in Crossref: 327] [Cited by in F6Publishing: 114] [Article Influence: 17.2] [Reference Citation Analysis]
Number Citing Articles
1 Pardee PE, Lavine JE, Schwimmer JB. Diagnosis and treatment of pediatric nonalcoholic steatohepatitis and the implications for bariatric surgery. Semin Pediatr Surg 2009;18:144-51. [PMID: 19573756 DOI: 10.1053/j.sempedsurg.2009.04.004] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
2 Dowla S, Pendergrass M, Bolding M, Gower B, Fontaine K, Ashraf A, Soleymani T, Morrison S, Goss A. Effectiveness of a carbohydrate restricted diet to treat non-alcoholic fatty liver disease in adolescents with obesity: Trial design and methodology. Contemp Clin Trials 2018;68:95-101. [PMID: 29601997 DOI: 10.1016/j.cct.2018.03.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
3 Petricevic N, Puharic Z, Posavec M, Pavic Simetin I, Pejnovic Franelic I. Family history and parental recognition of overweight in Croatian children. Eur J Pediatr 2012;171:1209-14. [PMID: 22415408 DOI: 10.1007/s00431-012-1707-7] [Cited by in Crossref: 7] [Article Influence: 0.7] [Reference Citation Analysis]
4 Lee SY, Sung E, Chang Y. Elevated serum gamma-glutamyltransferase is a strong marker of insulin resistance in obese children. Int J Endocrinol 2013;2013:578693. [PMID: 23573088 DOI: 10.1155/2013/578693] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
5 El-Koofy NM, Anwar GM, El-Raziky MS, El-Hennawy AM, El-Mougy FM, El-Karaksy HM, Hassanin FM, Helmy HM. The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children. Saudi J Gastroenterol. 2012;18:44-49. [PMID: 22249092 DOI: 10.4103/1319-3767.91738] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
6 Sundaram SS, Zeitler P, Nadeau K. The metabolic syndrome and nonalcoholic fatty liver disease in children. Curr Opin Pediatr 2009;21:529-35. [PMID: 19444112 DOI: 10.1097/MOP.0b013e32832cb16f] [Cited by in Crossref: 58] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
7 Ohmi S, Ono M, Takata H, Hirano S, Funakoshi S, Nishi Y, Yoshimura K, Amano E, Terada Y, Saibara T, Fujimoto S. Analysis of factors influencing glucose tolerance in Japanese patients with non-alcoholic fatty liver disease. Diabetol Metab Syndr 2017;9. [DOI: 10.1186/s13098-017-0264-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
8 Hamad EM, Taha SH, Abou Dawood AG, Sitohy MZ, Abdel-Hamid M. Protective effect of whey proteins against nonalcoholic fatty liver in rats. Lipids Health Dis 2011;10:57. [PMID: 21489294 DOI: 10.1186/1476-511X-10-57] [Cited by in Crossref: 49] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
9 Lustig RH, Mulligan K, Noworolski SM, Tai VW, Wen MJ, Erkin-Cakmak A, Gugliucci A, Schwarz JM. Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome. Obesity (Silver Spring) 2016;24:453-60. [PMID: 26499447 DOI: 10.1002/oby.21371] [Cited by in Crossref: 91] [Cited by in F6Publishing: 84] [Article Influence: 13.0] [Reference Citation Analysis]
10 Achmad E, Yokoo T, Hamilton G, Heba ER, Hooker JC, Changchien C, Schroeder M, Wolfson T, Gamst A, Schwimmer JB, Lavine JE, Sirlin CB, Middleton MS. Feasibility of and agreement between MR imaging and spectroscopic estimation of hepatic proton density fat fraction in children with known or suspected nonalcoholic fatty liver disease. Abdom Imaging 2015;40:3084-90. [PMID: 26205992 DOI: 10.1007/s00261-015-0506-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
11 Singendonk M, Kritas S, Omari T, Feinle-Bisset C, Page AJ, Frisby CL, Kentish SJ, Ferris L, McCall L, Kow L, Chisholm J, Khurana S. Upper Gastrointestinal Function in Morbidly Obese Adolescents Before and 6 Months After Gastric Banding. Obes Surg 2018;28:1277-88. [PMID: 29103072 DOI: 10.1007/s11695-017-3000-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
12 Lee JH, Jeong SJ. What is the appropriate strategy for diagnosing NAFLD using ultrasonography in obese children? World J Pediatr 2017;13:248-54. [PMID: 28101773 DOI: 10.1007/s12519-017-0008-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
13 Stewart MS, Heerwagen MJ, Friedman JE. Developmental programming of pediatric nonalcoholic fatty liver disease: redefining the"first hit". Clin Obstet Gynecol 2013;56:577-90. [PMID: 23835912 DOI: 10.1097/GRF.0b013e3182a09760] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 3.6] [Reference Citation Analysis]
14 Cree-Green M, Ravi S, Carreau AM, Sewell R, Baumgartner A, Coe G, Bergman BC, Scherzinger A, Jensen T, Pyle L, Nadeau KJ. Nonalcoholic fatty liver disease in obese adolescent females is associated with multi-tissue insulin resistance and visceral adiposity markers. Metabol Open 2019;2:100011. [PMID: 32812939 DOI: 10.1016/j.metop.2019.100011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
15 Fraser A, Longnecker MP, Lawlor DA. Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004. Gastroenterology. 2007;133:1814-1820. [PMID: 18054554 DOI: 10.1053/j.gastro.207.08.077] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Campos RM, de Piano A, da Silva PL, Carnier J, Sanches PL, Corgosinho FC, Masquio DC, Lazaretti-Castro M, Oyama LM, Nascimento CM. The role of pro/anti-inflammatory adipokines on bone metabolism in NAFLD obese adolescents: effects of long-term interdisciplinary therapy. Endocrine. 2012;42:146-156. [PMID: 22315014 DOI: 10.1007/s12020-012-9613] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Bellarosa C, Bedogni G, Bianco A, Cicolini S, Caroli D, Tiribelli C, Sartorio A. Association of Serum Bilirubin Level with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study of 1672 Obese Children. J Clin Med 2021;10:2812. [PMID: 34202304 DOI: 10.3390/jcm10132812] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Grotti Clemente AP, Molin Netto BD, Ganen Ad, Tock L, Arisa Caranti D, de Mello MT, Tufik S, Dâmaso AR. Cut-Off Values of Visceral Adiposity to Predict NAFLD in Brazilian Obese Adolescents. J Nutr Metab 2013;2013:724781. [PMID: 24381750 DOI: 10.1155/2013/724781] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
19 Mager D, Roberts E. Nonalcoholic fatty liver disease. CMAJ 2005;173:735; author reply 735. [PMID: 16186572 DOI: 10.1503/cmaj.1050122] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
20 Papandreou D, Andreou E. Role of diet on non-alcoholic fatty liver disease: An updated narrative review. World J Hepatol 2015; 7(3): 575-582 [PMID: 25848481 DOI: 10.4254/wjh.v7.i3.575] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
21 Pardee PE, Dunn W, Schwimmer JB. Non-alcoholic fatty liver disease is associated with low bone mineral density in obese children. Aliment Pharmacol Ther. 2012;35:248-254. [PMID: 22111971 DOI: 10.1111/j.1365-2036.2011.04924.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 5.0] [Reference Citation Analysis]
22 Newton KP, Hou J, Crimmins NA, Lavine JE, Barlow SE, Xanthakos SA, Africa J, Behling C, Donithan M, Clark JM, Schwimmer JB; Nonalcoholic Steatohepatitis Clinical Research Network. Prevalence of Prediabetes and Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease. JAMA Pediatr 2016;170:e161971. [PMID: 27478956 DOI: 10.1001/jamapediatrics.2016.1971] [Cited by in Crossref: 103] [Cited by in F6Publishing: 90] [Article Influence: 17.2] [Reference Citation Analysis]
23 Yang HR. Noninvasive diagnosis of pediatric nonalcoholic fatty liver disease. Korean J Pediatr 2013;56:45-51. [PMID: 23482433 DOI: 10.3345/kjp.2013.56.2.45] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
24 De Bruyne RM, Fitzpatrick E, Dhawan A. Fatty liver disease in children: eat now pay later. Hepatol Int. 2010;4:375-385. [PMID: 20305757 DOI: 10.1007/s12072-009-9160-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
25 Fermin CR, Lee AM, Filipp SL, Gurka MJ, DeBoer MD. Serum Alanine Aminotransferase Trends and Their Relationship with Obesity and Metabolic Syndrome in United States Adolescents, 1999-2014. Metab Syndr Relat Disord 2017;15:276-82. [PMID: 28520503 DOI: 10.1089/met.2017.0023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
26 Barshop NJ, Francis CS, Schwimmer JB, Lavine JE. Nonalcoholic fatty liver disease as a comorbidity of childhood obesity. Ped Health. 2009;3:271-281. [PMID: 20556232 DOI: 10.2217/phe.09.21] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
27 Marchesini G, Avagnina S, Barantani EG, Ciccarone AM, Corica F, Dall'Aglio E, Dalle Grave R, Morpurgo PS, Tomasi F, Vitacolonna E. Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome. J Endocrinol Invest. 2005;28:333-339. [PMID: 15966506 DOI: 10.1007/bf03347199] [Cited by in Crossref: 102] [Cited by in F6Publishing: 37] [Article Influence: 6.0] [Reference Citation Analysis]
28 St-Jules DE, Watters CA, Nagamori K, King J. The effect of weight loss on pediatric nonalcoholic Fatty liver disease. ISRN Gastroenterol. 2013;2013:398297. [PMID: 23781345 DOI: 10.1155/2013/398297] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Devadason CA, Scheimann AO. Overview of screening methods for fatty liver disease in children. World J Hepatol 2012; 4(1): 1-4 [PMID: 22312449 DOI: 10.4254/wjh.v4.i1.1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
30 Maj M, Harbottle B, Thomas PA, Hernandez GV, Smith VA, Edwards MS, Fanter RK, Glanz HS, Immoos C, Burrin DG, Santiago-Rodriguez TM, La Frano MR, Manjarín R. Consumption of High-Fructose Corn Syrup Compared with Sucrose Promotes Adiposity and Increased Triglyceridemia but Comparable NAFLD Severity in Juvenile Iberian Pigs. J Nutr 2021;151:1139-49. [PMID: 33693900 DOI: 10.1093/jn/nxaa441] [Reference Citation Analysis]
31 Dâmaso AR, de Piano A, Campos RM, Corgosinho FC, Siegfried W, Caranti DA, Masquio DC, Carnier J, Sanches Pde L, Leão da Silva P, Nascimento CM, Oyama LM, Dantas AD, de Mello MT, Tufik S, Tock L. Multidisciplinary approach to the treatment of obese adolescents: effects on cardiovascular risk factors, inflammatory profile, and neuroendocrine regulation of energy balance. Int J Endocrinol 2013;2013:541032. [PMID: 24285955 DOI: 10.1155/2013/541032] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
32 Takahashi Y, Fukusato T. Pediatric nonalcoholic fatty liver disease: Overview with emphasis on histology. World J Gastroenterol 2010; 16(42): 5280-5285 [PMID: 21072890 DOI: 10.3748/wjg.v16.i42.5280] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
33 Yanovski JA. Pediatric obesity. An introduction. Appetite 2015;93:3-12. [PMID: 25836737 DOI: 10.1016/j.appet.2015.03.028] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 6.1] [Reference Citation Analysis]
34 Manti S, Romano C, Chirico V, Filippelli M, Cuppari C, Loddo I, Salpietro C, Arrigo T. Nonalcoholic Fatty liver disease/non-alcoholic steatohepatitis in childhood: endocrine-metabolic “mal-programming”. Hepat Mon. 2014;14:e17641. [PMID: 24829591 DOI: 10.5812/hepatmon.17641] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
35 Almeida SS, Corgosinho FC, Amorim CE, Gregnani MF, Campos RM, Masquio DC, Sanches PL, Ganen AP, Pesquero JB, Dâmaso AR, Mello MT, Tufik S, Araújo RC. Different metabolic responses induced by long-term interdisciplinary therapy in obese adolescents related to ACE I/D polymorphism. J Renin Angiotensin Aldosterone Syst 2017;18:1470320317703451. [PMID: 28504003 DOI: 10.1177/1470320317703451] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Rausch JC, Lavine JE, Chalasani N, Guo X, Kwon S, Schwimmer JB, Molleston JP, Loomba R, Brunt EM, Chen YI, Goodarzi MO, Taylor KD, Yates KP, Rotter JI; NASH Clinical Research Network. Genetic Variants Associated With Obesity and Insulin Resistance in Hispanic Boys With Nonalcoholic Fatty Liver Disease. J Pediatr Gastroenterol Nutr 2018;66:789-96. [PMID: 29470286 DOI: 10.1097/MPG.0000000000001926] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
37 Hadjiyannakis S. The metabolic syndrome in children and adolescents. Paediatr Child Health 2005;10:41-7. [PMID: 19657446 DOI: 10.1093/pch/10.1.41] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
38 Kwon KA, Chun P, Park JH. Clinical significance of serum alanine aminotransferase and lifestyle intervention in children with nonalcoholic fatty liver disease. Korean J Pediatr 2016;59:362-7. [PMID: 27721840 DOI: 10.3345/kjp.2016.59.9.362] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
39 Li H, Canet MJ, Clarke JD, Billheimer D, Xanthakos SA, Lavine JE, Erickson RP, Cherrington NJ. Pediatric Cytochrome P450 Activity Alterations in Nonalcoholic Steatohepatitis. Drug Metab Dispos 2017;45:1317-25. [PMID: 28986475 DOI: 10.1124/dmd.117.077644] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
40 Ozturk Y, Soylu OB. Fatty liver in childhood. World J Hepatol 2014; 6(1): 33-40 [PMID: 24653792 DOI: 10.4254/wjh.v6.i1.33] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
41 Holzberg JR, Jin R, Le NA, Ziegler TR, Brunt EM, McClain CJ, Konomi JV, Arteel GE, Vos MB. Plasminogen Activator Inhibitor-1 Predicts Quantity of Hepatic Steatosis Independent of Insulin Resistance and Body Weight. J Pediatr Gastroenterol Nutr 2016;62:819-23. [PMID: 26704864 DOI: 10.1097/MPG.0000000000001096] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
42 Cioffi CE, Welsh JA, Cleeton RL, Caltharp SA, Romero R, Wulkan ML, Konomi JV, Frediani JK, Vos MB. Natural History of NAFLD Diagnosed in Childhood: A Single-Center Study. Children (Basel) 2017;4:E34. [PMID: 28467377 DOI: 10.3390/children4050034] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
43 Ko JS, Yoon JM, Yang HR, Myung JK, Kim H, Kang GH, Cheon JE, Seo JK. Clinical and histological features of nonalcoholic fatty liver disease in children. Dig Dis Sci. 2009;54:2225-2230. [PMID: 19697129 DOI: 10.1007/s10620-009-0949-3] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
44 Faienza MF, Chiarito M, Molina-Molina E, Shanmugam H, Lammert F, Krawczyk M, D'Amato G, Portincasa P. Childhood obesity, cardiovascular and liver health: a growing epidemic with age. World J Pediatr 2020;16:438-45. [PMID: 32020441 DOI: 10.1007/s12519-020-00341-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
45 Scapaticci S, D'Adamo E, Mohn A, Chiarelli F, Giannini C. Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes.Front Endocrinol (Lausanne). 2021;12:639548. [PMID: 33889132 DOI: 10.3389/fendo.2021.639548] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
46 Alberti G, Gana JC, Santos JL. Fructose, Omega 3 Fatty Acids, and Vitamin E: Involvement in Pediatric Non-Alcoholic Fatty Liver Disease. Nutrients 2020;12:E3531. [PMID: 33212947 DOI: 10.3390/nu12113531] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Fu JF, Shi HB, Liu LR, Jiang P, Liang L, Wang CL, Liu XY. Non-alcoholic fatty liver disease: An early mediator predicting metabolic syndrome in obese children? World J Gastroenterol 2011; 17(6): 735-742 [PMID: 21390143 DOI: 10.3748/wjg.v17.i6.735] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 48] [Article Influence: 4.5] [Reference Citation Analysis]
48 Güngör NK. Overweight and obesity in children and adolescents. J Clin Res Pediatr Endocrinol 2014;6:129-43. [PMID: 25241606 DOI: 10.4274/Jcrpe.1471] [Cited by in Crossref: 187] [Cited by in F6Publishing: 155] [Article Influence: 26.7] [Reference Citation Analysis]
49 Lee S, Kim Y, Kuk JL. What Is the Role of Resistance Exercise in Improving the Cardiometabolic Health of Adolescents with Obesity? J Obes Metab Syndr 2019;28:76-91. [PMID: 31294340 DOI: 10.7570/jomes.2019.28.2.76] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
50 Patel DA, Srinivasan SR, Chen W, Berenson GS. Serum alanine aminotransferase and its association with metabolic syndrome in children: the bogalusa heart study. Metab Syndr Relat Disord 2011;9:211-6. [PMID: 21476865 DOI: 10.1089/met.2010.0086] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
51 Kelishadi R, Cook SR, Adibi A, Faghihimani Z, Ghatrehsamani S, Beihaghi A, Salehi H, Khavarian N, Poursafa P. Association of the components of the metabolic syndrome with non-alcoholic fatty liver disease among normal-weight, overweight and obese children and adolescents. Diabetol Metab Syndr 2009;1:29. [PMID: 20028551 DOI: 10.1186/1758-5996-1-29] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 3.6] [Reference Citation Analysis]
52 Patton HM, Lavine JE, Van Natta ML, Schwimmer JB, Kleiner D, Molleston J; Nonalcoholic Steatohepatitis Clinical Research Network. Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis. Gastroenterology 2008;135:1961-1971.e2. [PMID: 19013463 DOI: 10.1053/j.gastro.2008.08.050] [Cited by in Crossref: 165] [Cited by in F6Publishing: 160] [Article Influence: 11.8] [Reference Citation Analysis]
53 Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, Benson JT, Enders FB, Angulo P. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut 2009;58:1538-44. [PMID: 19625277 DOI: 10.1136/gut.2008.171280] [Cited by in Crossref: 414] [Cited by in F6Publishing: 389] [Article Influence: 31.8] [Reference Citation Analysis]
54 Corgosinho FC, de Piano A, Sanches PL, Campos RM, Silva PL, Carnier J, Oyama LM, Tock L, Tufik S, de Mello MT, Dâmaso AR. The role of PAI-1 and adiponectin on the inflammatory state and energy balance in obese adolescents with metabolic syndrome. Inflammation 2012;35:944-51. [PMID: 22038064 DOI: 10.1007/s10753-011-9397-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
55 Andrade MI, Oliveira JS, Leal VS, Lima NM, Costa EC, Aquino NB, Lira PI. [Identification of cutoff points for Homeostatic Model Assessment for Insulin Resistance index in adolescents: systematic review]. Rev Paul Pediatr 2016;34:234-42. [PMID: 26559605 DOI: 10.1016/j.rpped.2015.08.006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
56 Uppal V, Mansoor S, Furuya KN. Pediatric Non-alcoholic Fatty Liver Disease. Curr Gastroenterol Rep 2016;18:24. [PMID: 27086005 DOI: 10.1007/s11894-016-0498-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
57 Guerrerio AL, Colvin RM, Schwartz AK, Molleston JP, Murray KF, Diehl A, Mohan P, Schwimmer JB, Lavine JE, Torbenson MS. Choline intake in a large cohort of patients with nonalcoholic fatty liver disease. Am J Clin Nutr. 2012;95:892-900. [PMID: 22338037 DOI: 10.3945/ajcn.111.020156] [Cited by in Crossref: 69] [Cited by in F6Publishing: 63] [Article Influence: 6.9] [Reference Citation Analysis]
58 Goyal NP, Schwimmer JB. The Progression and Natural History of Pediatric Nonalcoholic Fatty Liver Disease. Clin Liver Dis. 2016;20:325-338. [PMID: 27063272 DOI: 10.1016/j.cld.2015.10.003] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 10.4] [Reference Citation Analysis]
59 Modi AC, Loux TJ, Bell SK, Harmon CM, Inge TH, Zeller MH. Weight-specific health-related quality of life in adolescents with extreme obesity. Obesity (Silver Spring) 2008;16:2266-71. [PMID: 18719653 DOI: 10.1038/oby.2008.347] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]
60 Lavine JE, Schwimmer JB, Van Natta ML, Molleston JP, Murray KF, Rosenthal P, Abrams SH, Scheimann AO, Sanyal AJ, Chalasani N. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA. 2011;305:1659-1668. [PMID: 21521847 DOI: 10.1001/jama.2011.520.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
61 do Prado WL, de Piano A, Lazaretti-Castro M, de Mello MT, Stella SG, Tufik S, do Nascimento CM, Oyama LM, Lofrano MC, Tock L, Caranti DA, Dâmaso AR. Relationship between bone mineral density, leptin and insulin concentration in Brazilian obese adolescents. J Bone Miner Metab 2009;27:613-9. [PMID: 19466592 DOI: 10.1007/s00774-009-0082-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
62 Hizli S, Koçyigit A, Arslan N, Tuncel SA, Demircioglu F, Cakmakçi H, Büyükgebiz B. Hepatic artery resistance in children with obesity and fatty liver. Indian J Pediatr 2010;77:407-11. [PMID: 20422324 DOI: 10.1007/s12098-010-0045-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
63 Lim JS, Mietus-Snyder M, Valente A, Schwarz JM, Lustig RH. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol. 2010;7:251-264. [PMID: 20368739 DOI: 10.1038/nrgastro.2010.41] [Cited by in Crossref: 426] [Cited by in F6Publishing: 399] [Article Influence: 35.5] [Reference Citation Analysis]
64 Clemente AP, Netto BD, de Carvalho-Ferreira JP, da Silveira Campos RM, de Piano Ganen A, Tock L, de Mello MT, Dâmaso AR. [Waist circumference as a marker for screening nonalcoholic fatty liver disease in obese adolescents]. Rev Paul Pediatr 2016;34:47-55. [PMID: 26830602 DOI: 10.1016/j.rpped.2015.05.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
65 Abdelmalek MF, Suzuki A, Guy C, Unalp-Arida A, Colvin R, Johnson RJ, Diehl AM; Nonalcoholic Steatohepatitis Clinical Research Network. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology. 2010;51:1961-1971. [PMID: 20301112 DOI: 10.1002/hep.23535] [Cited by in Crossref: 451] [Cited by in F6Publishing: 421] [Article Influence: 37.6] [Reference Citation Analysis]
66 Wabitsch M, Moss A, Reinehr T, Wiegand S, Kiess W, Scherag A, Holl R, Holle R, Hebebrand J. Medical and psychosocial implications of adolescent extreme obesity - acceptance and effects of structured care, short: Youth with Extreme Obesity Study (YES). BMC Public Health 2013;13:789. [PMID: 23987123 DOI: 10.1186/1471-2458-13-789] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
67 Rehm JL, Wolfgram PM, Hernando D, Eickhoff JC, Allen DB, Reeder SB. Proton density fat-fraction is an accurate biomarker of hepatic steatosis in adolescent girls and young women. Eur Radiol. 2015;25:2921-2930. [PMID: 25916386 DOI: 10.1007/s00330-015-3724-1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 5.4] [Reference Citation Analysis]
68 Pacifico L, Poggiogalle E, Cantisani V, Menichini G, Ricci P, Ferraro F, Chiesa C. Pediatric nonalcoholic fatty liver disease: A clinical and laboratory challenge. World J Hepatol 2010; 2(7): 275-288 [PMID: 21161009 DOI: 10.4254/wjh.v2.i7.275] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
69 Bianchini JAA, da Silva DF, Hintze LJ, Antonini VDS, Lopera CA, Mcneil J, Nardo Junior N. Obese adolescents who gained/maintained or lost weight had similar body composition and cardiometabolic risk factors following a multidisciplinary intervention. Journal of Exercise Science & Fitness 2014;12:38-45. [DOI: 10.1016/j.jesf.2014.04.001] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
70 Denzer C. [Non-alcoholic fatty liver disease in obese children and adolescents]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013;56:517-27. [PMID: 23529597 DOI: 10.1007/s00103-012-1639-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
71 Christon LM, Weber A, Lesher A, Crowley N, Jones M, Byrne TK, Wedin S. Transition Readiness in Adolescents with Severe Obesity Presenting for Bariatric and Metabolic Surgery. Bariatric Surgical Practice and Patient Care 2018;13:98-102. [DOI: 10.1089/bari.2018.0012] [Reference Citation Analysis]
72 Schwimmer JB, Pardee PE, Lavine JE, Blumkin AK, Cook S. Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. Circulation. 2008;118:277-283. [PMID: 18591439 DOI: 10.1161/circulationaha.107.739920] [Cited by in Crossref: 246] [Cited by in F6Publishing: 133] [Article Influence: 17.6] [Reference Citation Analysis]
73 Mogahed EA, Sayed AA, Khalifa SE, El-Hennawy A, El-Raziky MS. Causes of secondary non-alcoholic fatty liver disease in non-obese children below 10 years. Eur J Pediatr 2020;179:719-26. [PMID: 31897838 DOI: 10.1007/s00431-019-03551-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
74 Pacifico L, Perla FM, Roggini M, Andreoli G, D'Avanzo M, Chiesa C. A Systematic Review of NAFLD-Associated Extrahepatic Disorders in Youths. J Clin Med 2019;8:E868. [PMID: 31213030 DOI: 10.3390/jcm8060868] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
75 Zaproudina N, Närhi M, Veijalainen A, Laitinen T, Lakka TA. Finger skin temperatures in 8- to 11-year-old children: determinants including physical characteristics and seasonal variation. The Physical Activity and Nutrition in Children (PANIC) Study. Eur J Appl Physiol 2016;116:405-13. [PMID: 26611892 DOI: 10.1007/s00421-015-3297-3] [Reference Citation Analysis]
76 Moura LP, Figueredo GA, Bertolini NO, Ceccato M, Pereira JR, Sponton AC, de Mello MA. Dietary restriction, caloric value and the accumulation of hepatic fat. Lipids Health Dis 2012;11:2. [PMID: 22221448 DOI: 10.1186/1476-511X-11-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
77 Lavine JE, Schwimmer JB, Van Natta ML, Molleston JP, Murray KF, Rosenthal P, Abrams SH, Scheimann AO, Sanyal AJ, Chalasani N, Tonascia J, Ünalp A, Clark JM, Brunt EM, Kleiner DE, Hoofnagle JH, Robuck PR; Nonalcoholic Steatohepatitis Clinical Research Network. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA 2011;305:1659-68. [PMID: 21521847 DOI: 10.1001/jama.2011.520] [Cited by in Crossref: 662] [Cited by in F6Publishing: 582] [Article Influence: 60.2] [Reference Citation Analysis]
78 Conjeevaram Selvakumar PK, Kabbany MN, Alkhouri N. Nonalcoholic Fatty Liver Disease in Children: Not a Small Matter. Paediatr Drugs. 2018;20:315-329. [PMID: 29740791 DOI: 10.1007/s40272-018-0292-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
79 Saki F, Karamizadeh Z. Metabolic syndrome, insulin resistance and Fatty liver in obese Iranian children. Iran Red Crescent Med J 2014;16:e6656. [PMID: 25031864 DOI: 10.5812/ircmj.6656] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
80 Hernandez GV, Smith VA, Melnyk M, Burd MA, Sprayberry KA, Edwards MS, Peterson DG, Bennet DC, Fanter RK, Columbus DA, Steibel JP, Glanz H, Immoos C, Rice MS, Santiago-Rodriguez TM, Blank J, VanderKelen JJ, Kitts CL, Piccolo BD, La Frano MR, Burrin DG, Maj M, Manjarin R. Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH. Am J Physiol Gastrointest Liver Physiol 2020;318:G582-609. [PMID: 32003601 DOI: 10.1152/ajpgi.00344.2019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
81 Bettermann K, Hohensee T, Haybaeck J. Steatosis and steatohepatitis: complex disorders. Int J Mol Sci. 2014;15:9924-9944. [PMID: 24897026 DOI: 10.3390/ijms15069924] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
82 Lavine JE, Schwimmer JB, Molleston JP, Scheimann AO, Murray KF, Abrams SH, Rosenthal P, Sanyal AJ, Robuck PR, Brunt EM, Unalp A, Tonascia J; Nonalcoholic Steatohepatitis Clinical Research Network Research Group. Treatment of nonalcoholic fatty liver disease in children: TONIC trial design. Contemp Clin Trials 2010;31:62-70. [PMID: 19761871 DOI: 10.1016/j.cct.2009.09.001] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 4.1] [Reference Citation Analysis]
83 Mărginean CO, Meliț LE, Săsăran MO. Metabolic Associated Fatty Liver Disease in Children-From Atomistic to Holistic. Biomedicines 2021;9:1866. [PMID: 34944682 DOI: 10.3390/biomedicines9121866] [Reference Citation Analysis]
84 Manco M. Insulin Resistance and NAFLD: A Dangerous Liaison beyond the Genetics. Children (Basel) 2017;4:E74. [PMID: 28805745 DOI: 10.3390/children4080074] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
85 Ho M, Garnett SP, Baur LA. Childhood obesity and insulin resistance: how should it be managed? Curr Treat Options Cardiovasc Med 2014;16:351. [PMID: 25293340 DOI: 10.1007/s11936-014-0351-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
86 Ferreira YAM, Kravchychyn ACP, Vicente SCF, Campos RMDS, Tock L, Oyama LM, Boldarine VT, Masquio DCL, Thivel D, Shivappa N, Hébert JR, Dâmaso AR. An Interdisciplinary Weight Loss Program Improves Body Composition and Metabolic Profile in Adolescents With Obesity: Associations With the Dietary Inflammatory Index. Front Nutr 2019;6:77. [PMID: 31214594 DOI: 10.3389/fnut.2019.00077] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
87 Geier A, Tiniakos D, Denk H, Trauner M. From the origin of NASH to the future of metabolic fatty liver disease. Gut 2021:gutjnl-2020-323202. [PMID: 33632710 DOI: 10.1136/gutjnl-2020-323202] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
88 Schwimmer JB, Dunn W, Norman GJ, Pardee PE, Middleton MS, Kerkar N, Sirlin CB. SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. Gastroenterology. 2010;138:1357-1364, 1364.e1-2. [PMID: 20064512 DOI: 10.1053/j.gastro.2009.12.052] [Cited by in Crossref: 248] [Cited by in F6Publishing: 233] [Article Influence: 20.7] [Reference Citation Analysis]
89 Zeller MH, Modi AC, Noll JG, Long JD, Inge TH. Psychosocial functioning improves following adolescent bariatric surgery. Obesity (Silver Spring) 2009;17:985-90. [PMID: 19165158 DOI: 10.1038/oby.2008.644] [Cited by in Crossref: 95] [Cited by in F6Publishing: 75] [Article Influence: 7.3] [Reference Citation Analysis]
90 Rajindrajith S, Dassanayake AS, Hewavisenthi J, de Silva HJ. Advanced hepatic fibrosis and cirrhosis due to nonalcoholic fatty liver disease in Sri Lankan children: a preliminary report. Hepatol Int 2008;2:209-12. [PMID: 19669306 DOI: 10.1007/s12072-008-9062-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
91 Sakurai M, Takamura T, Ota T, Ando H, Akahori H, Kaji K, Sasaki M, Nakanuma Y, Miura K, Kaneko S. Liver steatosis, but not fibrosis, is associated with insulin resistance in nonalcoholic fatty liver disease. J Gastroenterol. 2007;42:312-317. [PMID: 17464461 DOI: 10.1007/s00535-006-1948-] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
92 Peng L, Wu S, Zhou N, Zhu S, Liu Q, Li X. Clinical characteristics and risk factors of nonalcoholic fatty liver disease in children with obesity.BMC Pediatr. 2021;21:122. [PMID: 33711964 DOI: 10.1186/s12887-021-02595-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Gökçe S, Atbinici Z, Aycan Z, Çınar HG, Zorlu P. The Relationship Between Pediatric Nonalcoholic Fatty Liver Disease and Cardiovascular Risk Factors and Increased Risk of Atherosclerosis in Obese Children. Pediatr Cardiol 2013;34:308-15. [DOI: 10.1007/s00246-012-0447-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
94 Özcan HN, Oğuz B, Haliloğlu M, Orhan D, Karçaaltıncaba M. Imaging patterns of fatty liver in pediatric patients. Diagn Interv Radiol 2015;21:355-60. [PMID: 26027765 DOI: 10.5152/dir.2015.14505] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
95 Nissen A, Fonvig CE, Chabanova E, Bøjsøe C, Trier C, Pedersen O, Hansen T, Thomsen HS, Holm JC. 1H-MRS measured ectopic fat in liver and muscle is associated with the metabolic syndrome in Danish girls but not in boys with overweight and obesity. Obes Sci Pract 2016;2:376-84. [PMID: 28090342 DOI: 10.1002/osp4.61] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
96 Hesham A-Kader H. Nonalcoholic fatty liver disease in children living in the obeseogenic society. World J Pediatr. 2009;5:245-254. [PMID: 19911138 DOI: 10.1007/s12519-009-0048-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
97 Schwimmer JB, Newton KP, Awai HI, Choi LJ, Garcia MA, Ellis LL, Vanderwall K, Fontanesi J. Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2013;38:1267-77. [PMID: 24117728 DOI: 10.1111/apt.12518] [Cited by in Crossref: 96] [Cited by in F6Publishing: 88] [Article Influence: 10.7] [Reference Citation Analysis]
98 Foroughi M, Maghsoudi Z, Askari G. The effect of vitamin D supplementation on blood sugar and different indices of insulin resistance in patients with non-alcoholic fatty liver disease (NAFLD). Iran J Nurs Midwifery Res 2016;21:100-4. [PMID: 26985230 DOI: 10.4103/1735-9066.174759] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
99 Saad V, Wicklow B, Wittmeier K, Hay J, MacIntosh A, Venugopal N, Ryner L, Berard L, McGavock J. A clinically relevant method to screen for hepatic steatosis in overweight adolescents: a cross sectional study. BMC Pediatr 2015;15:151. [PMID: 26450572 DOI: 10.1186/s12887-015-0465-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
100 Hattar LN, Wilson TA, Tabotabo LA, Smith EO, Abrams SH. Physical activity and nutrition attitudes in obese Hispanic children with non-alcoholic steatohepatitis. World J Gastroenterol 2011; 17(39): 4396-4403 [PMID: 22110265 DOI: 10.3748/wjg.v17.i39.4396] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
101 Tock L, Dâmaso AR, de Piano A, Carnier J, Sanches PL, Lederman HM, Ernandes RM, de Mello MT, Tufik S. Long-term effects of metformin and lifestyle modification on nonalcoholic Fatty liver disease obese adolescents. J Obes 2010;2010:831901. [PMID: 20798858 DOI: 10.1155/2010/831901] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
102 Nwosu BU, Maranda L. The effects of vitamin D supplementation on hepatic dysfunction, vitamin D status, and glycemic control in children and adolescents with vitamin D deficiency and either type 1 or type 2 diabetes mellitus. PLoS One. 2014;9:e99646. [PMID: 24918447 DOI: 10.1371/journal.pone.0099646] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
103 Pirgon Ö, Bilgin H, Çekmez F, Kurku H, Dündar BN. Association between insulin resistance and oxidative stress parameters in obese adolescents with non-alcoholic fatty liver disease. J Clin Res Pediatr Endocrinol. 2013;5:33-39. [PMID: 23367495 DOI: 10.4274/jcrpe.825] [Cited by in Crossref: 35] [Cited by in F6Publishing: 21] [Article Influence: 3.9] [Reference Citation Analysis]
104 Cunha GM, Guzman G, Correa De Mello LL, Trein B, Spina L, Bussade I, Marques Prata J, Sajoux I, Countinho W. Efficacy of a 2-Month Very Low-Calorie Ketogenic Diet (VLCKD) Compared to a Standard Low-Calorie Diet in Reducing Visceral and Liver Fat Accumulation in Patients With Obesity. Front Endocrinol (Lausanne) 2020;11:607. [PMID: 33042004 DOI: 10.3389/fendo.2020.00607] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
105 Ranucci G, Spagnuolo MI, Iorio R. Obese children with fatty liver: Between reality and disease mongering. World J Gastroenterol 2017; 23(47): 8277-8282 [PMID: 29307987 DOI: 10.3748/wjg.v23.i47.8277] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
106 Bush H, Golabi P, Younossi ZM. Pediatric Non-Alcoholic Fatty Liver Disease. Children (Basel) 2017;4:E48. [PMID: 28598410 DOI: 10.3390/children4060048] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
107 Radulescu A, Dugan AJ, Killian M, Attia SL, Mouzaki M, Fuchs GJ, Kohli R, Bada H, Kern PA, Softic S. Stratification by obesity class, rather than age, can identify a higher percent of children at risk for non-alcoholic fatty liver disease and metabolic dysfunction. Pediatr Obes 2021;:e12862. [PMID: 34662928 DOI: 10.1111/ijpo.12862] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Rocha R, Cotrim HP, Bitencourt AGV, Barbosa DBV, Santos AS, Almeida AM, Cunha B, Guimarães I. Nonalcoholic fatty liver disease in asymptomatic Brazilian adolescents. World J Gastroenterol 2009; 15(4): 473-477 [PMID: 19152453 DOI: 10.3748/wjg.15.473] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
109 Yoon J, Park BH, Kim JH, Moon JH, Lee YH, Jang SM, Kim YJ. Investigation of Clinical and Pathological Relationships between Adult- and Pediatric-type NASH in Korean Children. J Korean Med Sci 2018;33:e34. [PMID: 29349944 DOI: 10.3346/jkms.2018.33.e34] [Reference Citation Analysis]
110 Hadjiyannakis S, Buchholz A, Chanoine JP, Jetha MM, Gaboury L, Hamilton J, Birken C, Morrison KM, Legault L, Bridger T, Cook SR, Lyons J, Sharma AM, Ball GD. The Edmonton Obesity Staging System for Pediatrics: A proposed clinical staging system for paediatric obesity. Paediatr Child Health 2016;21:21-6. [PMID: 26941556 DOI: 10.1093/pch/21.1.21] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
111 Vos MB, Barve S, Joshi-Barve S, Carew JD, Whitington PF, McClain CJ. Cytokeratin 18, a marker of cell death, is increased in children with suspected nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr. 2008;47:481-485. [PMID: 18852641 DOI: 10.1097/mpg.0b013e31817e2bfb] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
112 Pardee PE, Dunn W, Schwimmer JB. Non-alcoholic fatty liver disease is associated with low bone mineral density in obese children. Aliment Pharmacol Ther. 2012;35:248-254. [PMID: 22111971 DOI: 10.1111/j.1365-2036.2011] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
113 Tabbaa A, Shaker M, Lopez R, Hoshemand K, Nobili V, Alkhouri N. Low Serum Potassium Levels Associated with Disease Severity in Children with Nonalcoholic Fatty Liver Disease. Pediatr Gastroenterol Hepatol Nutr. 2015;18:168-174. [PMID: 26473136 DOI: 10.5223/pghn.2015.18.3.168] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
114 Bahar A, Kashi Z, Sohrab M, Kosaryan M, Janbabai G. Relationship between beta-globin gene carrier state and insulin resistance. J Diabetes Metab Disord 2012;11:22. [PMID: 23497547 DOI: 10.1186/2251-6581-11-22] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
115 Rehm JL, Connor EL, Wolfgram PM, Eickhoff JC, Reeder SB, Allen DB. Predicting hepatic steatosis in a racially and ethnically diverse cohort of adolescent girls. J Pediatr 2014;165:319-325.e1. [PMID: 24857521 DOI: 10.1016/j.jpeds.2014.04.019] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
116 Koot BG, van der Baan-Slootweg OH, Vinke S, Bohte AE, Tamminga-Smeulders CL, Jansen PL, Stoker J, Benninga MA. Intensive lifestyle treatment for non-alcoholic fatty liver disease in children with severe obesity: inpatient versus ambulatory treatment. Int J Obes (Lond) 2016;40:51-7. [PMID: 26315844 DOI: 10.1038/ijo.2015.175] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
117 Corte CD, Ferrari F, Villani A, Nobili V. Epidemiology and Natural History of NAFLD. J Med Biochem 2015;34:13-7. [PMID: 28356818 DOI: 10.2478/jomb-2014-0049] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
118 Rajindrajith S, Pathmeswaran A, Jayasinghe C, Kottahachchi D, Kasturiratne A, de Silva ST, Niriella MA, Dassanayake AS, de Silva AP, de Silva HJ. Non-alcoholic fatty liver disease and its associations among adolescents in an urban, Sri Lankan community. BMC Gastroenterol 2017;17:135. [PMID: 29187144 DOI: 10.1186/s12876-017-0677-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
119 Sheldon RD, Kanosky KM, Wells KD, Miles L, Perfield JW 2nd, Xanthakos S, Inge TH, Rector RS. Transcriptomic differences in intra-abdominal adipose tissue in extremely obese adolescents with different stages of NAFLD. Physiol Genomics 2016;48:897-911. [PMID: 27764764 DOI: 10.1152/physiolgenomics.00020.2016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
120 Fraser A, Longnecker MP, Lawlor DA. Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004. Gastroenterology. 2007;133:1814-1820. [PMID: 18054554 DOI: 10.1053/j.gastro.2007.08.077] [Cited by in Crossref: 222] [Cited by in F6Publishing: 219] [Article Influence: 14.8] [Reference Citation Analysis]